Text Size
50 studies found for:    Alzheimer's disease | United States, Alabama

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed
Has Results 		A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Dimebon;   Drug: Placebo
2 Completed Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)
Conditions: Dementia;   Alzheimer's Disease
Intervention: Drug: Rasagiline
3 Completed Effects of ONO-2506PO in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: ONO-2506PO
4 Terminated
Has Results 		An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Dimebon
5 Completed Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: AC-3933
6 Completed CATIE-Alzheimer's Disease Trial
Condition: Alzheimer's Disease
Interventions: Drug: Olanzapine;   Drug: Quetiapine;   Drug: Risperidone;   Drug: Citalopram
7 Recruiting Alzheimer's Disease Neuroimaging Initiative 2
Conditions: Mild Cognitive Impairment (MCI);   Alzheimer's Disease
Intervention:
8 Completed Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia
Intervention: Drug: Donepezil hydrochloride
9 Completed A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: PF-04447943;   Drug: Placebo
10 Active, not recruiting Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Genetic: CERE-110: Adeno-Associated Virus Delivery of NGF;   Procedure: Placebo Surgery
11 Terminated A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Bapineuzumab
12 Completed Alzheimer's Disease Prevention Trial
Conditions: Alzheimer Disease;   Memory Disorders
Interventions: Drug: Estrogen;   Drug: Estrogen and Progesterone
13 Completed A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease
Condition: Alzheimer´s Disease
Interventions: Drug: Immune Globulin Intravenous (Human), 10% (IGIV, 10%);   Other: Placebo solution
14 Terminated A Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease Patients
Condition: Alzheimer Disease
Intervention: Drug: Bapineuzumab 0.5 mg/kg
15 Completed Multicenter Trial of Prednisone in Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: Prednisone
16 Terminated Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol
Condition: Alzheimer's Disease
Intervention: Drug: MPC-7869
17 Completed Observational Study on Costs and Caregiver Burden in Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention:
18 Completed Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Conditions: Mild Cognitive Impairment;   Alzheimer's Disease
Intervention:
19 Completed Evaluation of Galantamine in the Treatment of Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: Galantamine
20 Completed ADNI: Alzheimer's Disease Neuroimaging Initiative
Condition: Alzheimer's Disease
Interventions: Procedure: Magnetic Resonance Imaging (MRI);   Procedure: Positron Emission Tomography (PET);   Procedure: Lumbar Puncture (LP)
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years